Security Snapshot

MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value (MYNZ) Institutional Ownership

CUSIP: N5436L101

13F Institutional Holders and Ownership History from Q4 2021 to Q4 2024

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
489,733,060
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • MYNZ - MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value is tracked under CUSIP N5436L101.
  • Latest finished 13F holder period is not available.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 11 to 0 between Q3 2024 and Q4 2024.
  • SEC-reported value moved from $45,256 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

N5436L101

Latest holder period

n/a

13F holders

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
MYNZ
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lazar David E. 97% 477,000,000 Lazar David E. 22 Apr 2026
Donahue Kevin Michael 11% 685,000 Donahue Kevin Michael 17 Oct 2025

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
13
Latest
n/a
Rows shown
1-13 of 13
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q4 0 $0 -$45,256 0
2024 Q3 181,873 $45,256 +$22,236 $0.25 11
2024 Q2 103,313 $41,429 -$33,055 $0.40 9
2024 Q1 146,767 $150,825 -$97,454 $1.03 12
2023 Q4 231,967 $268,673 +$237,604 $1.16 11
2023 Q3 20,149 $59,220 +$2,938 $2.92 8
2023 Q2 19,077 $90,508 -$5,057 $4.78 9
2023 Q1 20,136 $125,901 +$214 $6.28 6
2022 Q4 20,102 $135,392 +$24,313 $7.10 6
2022 Q3 15,634 $108,000 -$11,587 $7.14 4
2022 Q2 16,840 $156,000 -$11,772 $9.31 3
2022 Q1 17,408 $254,000 +$7,419 $14.60 5
2021 Q4 20,303 $210,000 +$210,000 $10.34 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .